Fulvestrant and Anastrozole in Combination: FACT or Fiction?
04/30/12 • 9 min
Previous Episode
A New Day Dawning for Hodgkin Lymphoma?
This podcast describes a phase 2 trial brentuximab vedotin in patients with Hodgkin lymphoma that has recurred after autologous hematopoietic stem cell transplantation. The podcast discusses the rationale for the trial, response to therapy, and associated toxicities. Future application of brentuximab vedotin to CD30+ malignancies is considered as well.
Next Episode
Pre-Operative Metformin in Early-Stage Breast Cancer
This podcast reviews the rationale behind evaluation of metformin as a potential anti-cancer agent in breast cancer and describes the findings of a recent window of opportunity trial looking at the impact of metformin upon proliferative indices in women with early breast cancer.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/journal-of-clinical-oncology-jco-podcast-448/fulvestrant-and-anastrozole-in-combination-fact-or-fiction-67843"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to fulvestrant and anastrozole in combination: fact or fiction? on goodpods" style="width: 225px" /> </a>
Copy